Detalhe da pesquisa
1.
Predictive In Vivo Models for Oncology.
Handb Exp Pharmacol;
232: 203-21, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26489829
2.
EPI-X4, a CXCR4 antagonist inhibits tumor growth in pancreatic cancer and lymphoma models.
Peptides;
175: 171111, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38036098
3.
Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylation.
Clin Epigenetics;
16(1): 13, 2024 01 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38229153
4.
Establishment and Thorough Characterization of Xenograft (PDX) Models Derived from Patients with Pancreatic Cancer for Molecular Analyses and Chemosensitivity Testing.
Cancers (Basel);
15(24)2023 Dec 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38136299
5.
Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity.
J Exp Clin Cancer Res;
42(1): 323, 2023 Nov 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38012687
6.
Animal models for personalized treatment options.
Int J Clin Pharmacol Ther;
55(8): 698-700, 2017 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28696202
7.
Effective Oncoleaking Treatment of Pancreatic Cancer by Claudin-Targeted Suicide Gene Therapy with Clostridium perfringens Enterotoxin (CPE).
Cancers (Basel);
13(17)2021 Aug 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34503203
8.
Bioengineered 3D models of human pancreatic cancer recapitulate in vivo tumour biology.
Nat Commun;
12(1): 5623, 2021 09 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34561461
9.
The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness.
Nat Commun;
11(1): 6422, 2020 12 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33349639
10.
TFEB-mediated lysosomal biogenesis and lysosomal drug sequestration confer resistance to MEK inhibition in pancreatic cancer.
Cell Death Discov;
6: 12, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32194992
11.
Human melanoma brain metastases cell line MUG-Mel1, isolated clones and their detailed characterization.
Sci Rep;
9(1): 4096, 2019 03 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30858407
12.
The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulators.
Oncotarget;
8(39): 66215-66225, 2017 Sep 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29029505
13.
Anti-cancer effects of bortezomib against chemoresistant neuroblastoma cell lines in vitro and in vivo.
Int J Oncol;
28(2): 439-46, 2006 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16391799
14.
Role of BCL9L in transforming growth factor-ß (TGF-ß)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
Oncotarget;
7(45): 73725-73738, 2016 Nov 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27713160
15.
Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3-MYC Interactions as a Target in Pancreatic Cancer.
Clin Cancer Res;
22(24): 6153-6163, 2016 Dec 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27384421
16.
Effect of sialyl Lewis X-glycoliposomes on the inhibition of E-selectin-mediated tumour cell adhesion in vitro.
Biochim Biophys Acta;
1660(1-2): 31-40, 2004 Jan 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-14757218
17.
The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells.
PLoS One;
9(5): e92596, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24799129
18.
Preclinical study on combined chemo- and nonviral gene therapy for sensitization of melanoma using a human TNF-alpha expressing MIDGE DNA vector.
Mol Oncol;
8(3): 609-19, 2014 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24503218
19.
Pancreatic cancer models for translational research.
Pharmacol Ther;
173: 146-158, 2017 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28174092
20.
Liposomal 4-hydroxy-tamoxifen: effect on cellular uptake and resulting cytotoxicity in drug resistant breast cancer cells in vitro.
Breast Cancer Res Treat;
87(3): 245-54, 2004 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15528967